Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026)

Phibro Animal Health's Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 24024000.0 for Q1 2026.

• On a quarterly basis, Income from Continuing Operations rose 15.06% year-over-year to 24024000.0 in Q1 2026; TTM through Mar 2026 was 95234000.0, a 783.22% increase from a year earlier, with the FY2025 full-year figure at 48264000.0, up 211.43% from the prior year.
• Income from Continuing Operations eased to 24024000.0 in Q1 2026 per PAHC's latest filing, from 27459000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 27459000.0 in Q4 2025 and bottomed at 44979000.0 in Q2 2024.
• The 5-year median for Income from Continuing Operations is 8405000.0 (2024), against an average of 8278882.35.
• Across the five-year window, Income from Continuing Operations tumbled 491.19% in 2024 and surged 762.14% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 7210000.0 in 2022, then sank by 82.33% to 1274000.0 in 2023, then jumped by 150.0% to 3185000.0 in 2024, then soared by 762.14% to 27459000.0 in 2025, then fell by 12.51% to 24024000.0 in 2026.
• Per Business Quant, the three latest PAHC Income from Continuing Operations figures stand at 24024000.0 (Q1 2026), 27459000.0 (Q4 2025), and 26527000.0 (Q3 2025).